Table 5.
Duration of grade IV neutropenia.
| Patients | Duration of grade IV neutropenia (days) | P | |
|---|---|---|---|
| Controls | Baxidil Onco® | ||
| Allogeneic HCST | 18.06±2.18 (n=18) | 17.50±2.47 (n=14) | NS |
| Autologous HCST | 9.21±0.97 (n=14) | 9.00±1.18 (n=14) | NS |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.